MRC1 and glioblastoma: Equally important, GAMs cocultured with pacritinib-treated U87MG and LN18 GBM cells showed a significantly reduced M2 marker (CD206) and increased M1 marker (TNF-α), strongly suggesting pacritinib not only suppressed GBM tumorigenesis but also affected GAM polarization.